A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)
Not Applicable
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002254
- Locations
- ๐บ๐ธ
Univ of North Carolina School of Medicine, Chapel Hill, North Carolina, United States
๐บ๐ธMem Sloan - Kettering Cancer Ctr, New York, New York, United States
๐บ๐ธJohns Hopkins Hosp, Baltimore, Maryland, United States
Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma
Phase 2
Completed
- Conditions
- Sarcoma, KaposiHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002259
- Locations
- ๐บ๐ธ
Saint Luke's - Roosevelt Hosp Ctr, New York, New York, United States
A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome
Not Applicable
Completed
- Conditions
- Pneumonia, Pneumocystis CariniiHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002002
- Locations
- ๐บ๐ธ
San Francisco Gen Hosp, San Francisco, California, United States
Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas
Phase 2
Completed
- Conditions
- Lymphoma, Non-HodgkinHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002003
- Locations
- ๐บ๐ธ
UMDNJ - New Jersy Med School, Newark, New Jersey, United States
๐บ๐ธNew York Univ Med Ctr, New York, New York, United States
๐บ๐ธSaint Luke's - Roosevelt Hosp Ctr, New York, New York, United States
An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects
Not Applicable
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002271
- Locations
- ๐บ๐ธ
Johns Hopkins Hosp, Baltimore, Maryland, United States
An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects
Not Applicable
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Lederle Laboratories
- Registration Number
- NCT00002260
- Locations
- ๐บ๐ธ
Johns Hopkins Hosp, Baltimore, Maryland, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath